Persium Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Persium Advisors's LLY Position: Q3 2026 in Review
Persium Advisors increased its Eli Lilly (LLY) stake by 5.5% in Q3 2026, buying an estimated $20.1K and bringing the position to 327 shares worth $378K. The position accounts for 0.2% of the portfolio, ranked #56.
Persium Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 987 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Persium Advisors held 327 shares of Eli Lilly worth $378K as of Q3 2026.
- Persium Advisors bought 17 Eli Lilly shares in Q3 2026, an estimated $20.1K.
- Eli Lilly made up 0.2% of Persium Advisors's portfolio in Q3 2026, its #56 holding.
- Persium Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 987 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Persium Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.